Improving Outcomes and Quality of Life After CABG

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00256620
First received: November 17, 2005
Last updated: March 31, 2008
Last verified: March 2008

November 17, 2005
March 31, 2008
December 1996
 
  • Quality of life
  • Cardiac morbidity
  • Neurologic morbidity
  • Mortality
  • Neurocognitive deterioration
Same as current
Complete list of historical versions of study NCT00256620 on ClinicalTrials.gov Archive Site
  • • To evaluate the prognostic importance of severe atheromatous disease of the descending aorta as found on transesophageal echocardiography (TEE) as a predictor of neurologic events.
  • • To correlate TEE and epiaortic scanning for aortic atheroma with transthoracic echocardiography (TTE) in order to develop a non-invasive screening tool.
  • • To assess the clinical significance of persistent post-operative depression as measured by the CES-D by using a structured clinical interview and to evaluate the relationship between pre-operative depression and the occurrence of cardiac, neurologic a
  • • To provide data on the mechanism of perioperative neurologic and cognitive complications in order to design other specific intervention to reduce postoperative morbidity.
Same as current
 
 
 
Improving Outcomes and Quality of Life After CABG
Improving Outcomes and Quality of Life After CABG

The principal objective to this randomized trial is to compare the efficacy of two strategies of intra-operative hemodynamic management during cardiopulmonary bypass among patients undergoing primary elective coronary artery bypass graft (CABG) surgery in preventing peri-operative cardiac, cognitive and neurologic morbidity and mortality and post-operative deterioration in the patient's quality of life as measured by the seven domains of SF-36 Health Survey (bodily pain, health perceptions, energy, and mental, physical, social and role function).

In one group, mean arterial pressure (MAP) was 65 mmHg. In the other, the MAP target was determined by the patients usual preoperative MAP. Thus, the trial will evaluate whether tailoring the MAP target for the period of cardiopulmonary bypass to within 10 mmHg of the patients usual MAP, but < 90 mmHg (and thus achieving pressures during bypass within the patients usual autoregulatory range) reduces major neurologic and cardiac morbidity and mortality, as well as cognitive complications, thereby improving post-operative quality of life.

Interventional
 
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind
Primary Purpose: Prevention
Coronary Artery Bypass Graft Surgery Patients
Procedure: Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized
 
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
412
December 1999
 

Inclusion Criteria:

  • All patients undergoing primary elective/urgent coronary artery bypass graft (CABG) surgery.

Exclusion Criteria:

  • Patients who elect not to participate in the study
  • Patients undergoing valve replacement or other cardiovascular surgical procedures
  • Patients who are not fluent in English
  • Patient who cannot provide informed written consent
Both
35 Years to 89 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00256620
9407000398 Formerly 0794-502CR
No
Mary E. Charlson, MD, Weill Cornell Medical College
Weill Medical College of Cornell University
National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Mary E Charlson, MD Weill Medical College of Cornell University
Principal Investigator: Karl Krieger, MD Weill Medical College of Cornell University
Weill Medical College of Cornell University
March 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP